163 related articles for article (PubMed ID: 29387209)
1. Chemotherapy of metastatic hepatoid adenocarcinoma: Literature review and two case reports with cisplatin etoposide.
Simmet V; Noblecourt M; Lizée T; Morvant B; Girault S; Soulié P; Capitain O
Oncol Lett; 2018 Jan; 15(1):48-54. PubMed ID: 29387209
[TBL] [Abstract][Full Text] [Related]
2. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C;
J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987
[TBL] [Abstract][Full Text] [Related]
3. Liver Metastasis of Hepatoid Colonic Adenocarcinoma: A Rare and Unusual Entity With Poor Prognosis and Review of the Literature.
Hu M; Liu W; Yin F; Zhang D; Liu X; Lai J
Gastroenterology Res; 2018 Dec; 11(6):430-435. PubMed ID: 30627268
[TBL] [Abstract][Full Text] [Related]
4. Alpha-Fetoprotein-Producing Lung Hepatoid Adenocarcinoma with Brain Metastasis Treated with S-1.
Muroyama Y; Tamiya H; Tanaka G; Tanaka W; Huang AC; Oldridge DA; Matsusaka K; Takazawa Y; Jo T; Ushiku T; Nagase T
Case Rep Oncol; 2020; 13(3):1552-1559. PubMed ID: 33564297
[TBL] [Abstract][Full Text] [Related]
5. Hepatoid adenocarcinoma of the stomach--proper identification and treatment remain a challenge.
Søreide JA; Greve OJ; Gudlaugsson E; Størset S
Scand J Gastroenterol; 2016; 51(6):646-53. PubMed ID: 26728165
[TBL] [Abstract][Full Text] [Related]
6. A phase II evaluation of high dose cisplatin and etoposide in patients with advanced esophageal adenocarcinoma.
Spiridonidis CH; Laufman LR; Jones JJ; Gray DJ; Cho CC; Young DC
Cancer; 1996 Nov; 78(10):2070-7. PubMed ID: 8918399
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant (cisplatin, etoposide, and 5-fluorouracil) chemotherapy after curative resection of gastric adenocarcinomas involving the esophagogastric junction.
Ryoo BY; Kang YK; Im YH; Kim YJ; Kim BS; Kim TY; Jung SH; Park JH; Baek HJ; Kim YC; Shim YM; Kim CM; Zo JI
Am J Clin Oncol; 1999 Jun; 22(3):253-7. PubMed ID: 10362331
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL)--a very effective regimen with good patients' compliance for advanced gastric cancer.
Cheng AL; Yeh KH; Lin JT; Hsu C; Liu MY
Anticancer Res; 1998; 18(2B):1267-72. PubMed ID: 9615799
[TBL] [Abstract][Full Text] [Related]
9. Hepatoid adenocarcinoma with liver metastasis mimicking hepatocellular carcinoma: an immunohistochemical and molecular study of eight cases.
Terracciano LM; Glatz K; Mhawech P; Vasei M; Lehmann FS; Vecchione R; Tornillo L
Am J Surg Pathol; 2003 Oct; 27(10):1302-12. PubMed ID: 14508391
[TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial.
Rajkumar SV; Frytak S; Rubin J; Camoriano JK; Fitch TR
Am J Clin Oncol; 1997 Oct; 20(5):500-4. PubMed ID: 9345336
[TBL] [Abstract][Full Text] [Related]
11. [Etoposide, epirubicin and cisplatin (EEP) combination in metastatic cancers of the cardia and the stomach. Groupe de recherche en cancérologie du Nord (GRECNO)].
Adenis A
Bull Cancer; 1994 Apr; 81(4):331-3. PubMed ID: 7703551
[TBL] [Abstract][Full Text] [Related]
12. Concurrent cisplatin, etoposide, and radiotherapy for unresectable stage III nonsmall cell lung cancer: a phase II study.
Reboul F; Brewer Y; Vincent P; Chauvet B; Faure CF; Taulelle M
Int J Radiat Oncol Biol Phys; 1996 May; 35(2):343-50. PubMed ID: 8635942
[TBL] [Abstract][Full Text] [Related]
13. Hepatoid adenocarcinoma of the lung: Review of a rare form of lung cancer.
Grossman K; Beasley MB; Braman SS
Respir Med; 2016 Oct; 119():175-179. PubMed ID: 27692141
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of cisplatin, etoposide and paclitaxel in locally advanced or metastatic adenocarcinoma of gastric/gastroesophageal junction.
Sharma A; Raina V; Lokeshwar N; Deo SV; Shukla NK; Mohanti BK
Indian J Cancer; 2006; 43(1):16-9. PubMed ID: 16763357
[TBL] [Abstract][Full Text] [Related]
15. Salvage Treatment for Advanced Gastric Cancer Using FEP (5-FU, Etoposide, Cisplatin) Combination Chemotherapy.
Chung JH; Bae YZ; Kim SH; Moon CH; Chung JY; Kwon HC; Kim JS; Kim HJ
Cancer Res Treat; 2002 Oct; 34(5):382-7. PubMed ID: 26680891
[TBL] [Abstract][Full Text] [Related]
16. Hepatoid adenocarcinoma of the lung metastasizing to the tonsil.
Valle L; Thomas J; Kim C; Szabo E; Brown GT; Citrin D; Rajan A
Mol Clin Oncol; 2017 May; 6(5):705-707. PubMed ID: 28529745
[TBL] [Abstract][Full Text] [Related]
17. Hepatoid adenocarcinoma of the stomach: A case report and literature review.
Liu XM; Chen GQ; Li SL; Zai TS
Exp Ther Med; 2015 Jun; 9(6):2133-2136. PubMed ID: 26136947
[TBL] [Abstract][Full Text] [Related]
18. Docetaxel and Cisplatin Plus Fluorouracil compared with Modified Docetaxel, Cisplatin, and 5-Fluorouracil as first-line therapy for advanced gastric cancer: a retrospective analysis of single institution.
Inal A; Kaplan MA; Kucukoner M; Isikdogan A
Neoplasma; 2012; 59(2):233-6. PubMed ID: 22248282
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial fo three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer Group.
Crino L; Tonato M; Darwish S; Meacci ML; Corgna E; Di Costanzo F; Buzzi F; Fornari G; Santi E; Ballatori E
Cancer Chemother Pharmacol; 1990; 26(1):52-6. PubMed ID: 2157554
[TBL] [Abstract][Full Text] [Related]
20. Taxane-based chemotherapy for patients with carcinoma of unknown primary site.
Greco FA; Gray J; Burris HA; Erland JB; Morrissey LH; Hainsworth JD
Cancer J; 2001; 7(3):203-12. PubMed ID: 11419028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
